Letter | Published:

A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis

Nature Medicine volume 14, pages 849854 (2008) | Download Citation

Subjects

Abstract

Acidification of the phagosome is considered to be a major mechanism used by macrophages against bacteria, including Mycobacterium tuberculosis (Mtb). Mtb blocks phagosome acidification1, but interferon-γ (IFN-γ) restores acidification and confers antimycobacterial activity2,3. Nonetheless, it remains unclear whether acid kills Mtb, whether the intrabacterial pH of any pathogen falls when it is in the phagosome and whether acid resistance is required for mycobacterial virulence. In vitro at pH 4.5, Mtb survived in a simple buffer and maintained intrabacterial pH. Therefore, Mtb resists phagolysosomal concentrations of acid. Mtb also maintained its intrabacterial pH and survived when phagocytosed by IFN-γ–activated macrophages. We used transposon mutagenesis to identify genes responsible for Mtb's acid resistance. A strain disrupted in Rv3671c, a previously uncharacterized gene encoding a membrane-associated protein, was sensitive to acid and failed to maintain intrabacterial pH in acid in vitro and in activated macrophages. Growth of the mutant was also severely attenuated in mice. Thus, Mtb is able to resist acid, owing in large part to Rv3671c, and this resistance is essential for virulence. Disruption of Mtb's acid resistance and intrabacterial pH maintenance systems is an attractive target for chemotherapy.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , & Immune control of tuberculosis by IFN-γ–inducible LRG-47. Science 302, 654–659 (2003).

  2. 2.

    , , & Cytokine activation leads to acidification and increases maturation of Mycobacterium avium–containing phagosomes in murine macrophages. J. Immunol. 160, 1290–1296 (1998).

  3. 3.

    et al. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111, 897–905 (1998).

  4. 4.

    Immunity to Infective Disease (Cambridge University Press, Cambridge, London, New York, 1905).

  5. 5.

    & Regulation of vacuolar pH and its modulation by some microbial species. Microbiol. Mol. Biol. Rev. 71, 452–462 (2007).

  6. 6.

    & Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75, 3327–3331 (1978).

  7. 7.

    & Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J. Exp. Med. 134, 713–740 (1971).

  8. 8.

    et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263, 678–681 (1994).

  9. 9.

    & Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181, 257–270 (1995).

  10. 10.

    , & Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages. Infect. Immun. 55, 680–685 (1987).

  11. 11.

    , , & Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158, 670–689 (1983).

  12. 12.

    et al. Local and systemic effects of intradermal recombinant interferon-γ in patients with lepromatous leprosy. N. Engl. J. Med. 315, 6–15 (1986).

  13. 13.

    et al. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J. Exp. Med. 178, 2243–2247 (1993).

  14. 14.

    et al. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249–2254 (1993).

  15. 15.

    et al. Clinical features of dominant and recessive interferon-γ receptor 1 deficiencies. Lancet 364, 2113–2121 (2004).

  16. 16.

    et al. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194, 1123–1140 (2001).

  17. 17.

    et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225–228 (1992).

  18. 18.

    et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94, 5243–5248 (1997).

  19. 19.

    & Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 142, 1–16 (1975).

  20. 20.

    et al. Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect. Immun. 67, 3199–3206 (1999).

  21. 21.

    & A genetic screen for Mycobacterium tuberculosis mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system. Infect. Immun. 75, 2668–2678 (2007).

  22. 22.

    et al. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc. Natl. Acad. Sci. USA 101, 13642–13647 (2004).

  23. 23.

    , , , & Mycobacterial mutants with defective control of phagosomal acidification. PLoS Pathog. 1, 269–278 (2005).

  24. 24.

    The effect of lipids and serum albumin on bacterial growth. J. Exp. Med. 85, 9–22 (1947).

  25. 25.

    & Antibacterial and cytotoxic aspects of long-chain fatty acids as cell surface events: selected topics. Jpn. J. Med. Sci. Biol. 32, 135–174 (1979).

  26. 26.

    , , & Cytosolic phospholipase A2 enzymes are not required by mouse bone marrow–derived macrophages for the control of Mycobacterium tuberculosis in vitro. Infect. Immun. 74, 1751–1756 (2006).

  27. 27.

    et al. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 178, 456–461 (1996).

  28. 28.

    , , , & The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302, 1963–1966 (2003).

  29. 29.

    et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537–544 (1998).

  30. 30.

    , , & The bacA gene of Escherichia coli encodes an undecaprenyl pyrophosphate phosphatase activity. J. Biol. Chem. 279, 30106–30113 (2004).

  31. 31.

    , & Involvement of Mycobacterium smegmatis undecaprenyl phosphokinase in biofilm and smegma formation. Microbes Infect. 6, 965–971 (2004).

  32. 32.

    , & MEROPS: the peptidase database. Nucleic Acids Res. 34, D270–D272 (2006).

  33. 33.

    , & Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 394, 192–195 (1998).

  34. 34.

    & Ammonium chloride, an inhibitor of phagosome-lysosome fusion in macrophages, concurrently induces phagosome-endosome fusion, and opens a novel pathway: studies of a pathogenic mycobacterium and a nonpathogenic yeast. J. Exp. Med. 174, 881–889 (1991).

  35. 35.

    & Immunity to tuberculosis. Annu. Rev. Immunol. 22, 599–623 (2004).

  36. 36.

    et al. Structure and function of the virulence-associated high-temperature requirement A of Mycobacterium tuberculosis. Biochemistry 47, 6092–6102 (2008).

  37. 37.

    , & Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe 2, 352–364 (2007).

  38. 38.

    & Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169, 1543–1555 (1989).

  39. 39.

    Antibiotics at the crossroads. Nature 431, 899–902 (2004).

  40. 40.

    et al. Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res. 33, e21 (2005).

Download references

Acknowledgements

We thank G. Miesenböck (Oxford University) for providing ratiometric pH-GFP; F. Maxfield, J. Roberts and T. Odaira for guidance and support; and L. Cohen-Gould and T. Labissiere at the Electron Microscopy and Histology Core Facilities at Weill Cornell Medical College and Hospital for Special Surgery for assistance with electron microscopy. This work is supported by the US National Institutes of Health (grant PO1 AI056293 to C.F.N.) and the I.T. Hirschl Trust (S.E.). The Department of Microbiology and Immunology acknowledges the support of the William Randolph Hearst Foundation.

Author information

Affiliations

  1. Departments of Microbiology and Immunology. Weill Cornell Medical College, 1300 York Avenue, New York, New York 10065, USA.

    • Omar H Vandal
    • , Lynda M Pierini
    • , Dirk Schnappinger
    • , Carl F Nathan
    •  & Sabine Ehrt
  2. Department of Biochemistry, Weill Cornell Medical College, 1300 York Avenue, New York, New York 10065, USA.

    • Lynda M Pierini

Authors

  1. Search for Omar H Vandal in:

  2. Search for Lynda M Pierini in:

  3. Search for Dirk Schnappinger in:

  4. Search for Carl F Nathan in:

  5. Search for Sabine Ehrt in:

Contributions

O.H.V. designed and performed experiments. L.M.P. guided fluorescent microscopy experiments, including their analysis. D.S. guided experimental design and provided constructs. C.F.N. and S.E. guided the study. O.H.V., C.F.N. and S.E. wrote the paper. All authors discussed the results and commented on the manuscript.

Corresponding authors

Correspondence to Carl F Nathan or Sabine Ehrt.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figs. 1–9 and Supplementary Table 1

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nm.1795

Further reading